Search

Your search keyword '"Kim, Kyung Soo"' showing total 2,504 results

Search Constraints

Start Over You searched for: Author "Kim, Kyung Soo" Remove constraint Author: "Kim, Kyung Soo"
2,504 results on '"Kim, Kyung Soo"'

Search Results

4. Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion

5. A Compact Optical Six-Axis Force/Torque Sensor for Legged Robots Using a Polymorphic Calibration Method

6. DualRefine: Self-Supervised Depth and Pose Estimation Through Iterative Epipolar Sampling and Refinement Toward Equilibrium

7. Lightweight HDR Camera ISP for Robust Perception in Dynamic Illumination Conditions via Fourier Adversarial Networks

8. DGSS : Domain Generalized Semantic Segmentation using Iterative Style Mining and Latent Representation Alignment

10. Correlate-and-Excite: Real-Time Stereo Matching via Guided Cost Volume Excitation

14. Evaluating COPY-BLEND Augmentation for Low Level Vision Tasks

15. Towards Domain Invariant Single Image Dehazing

18. Retaining Image Feature Matching Performance Under Low Light Conditions

19. Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

20. Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

26. Output feedback based event-triggered sliding mode control for delta operator systems

29. Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: a double-blind, randomized, comparator-active study: ENHANCE-D study

35. Coupled fixed point theorems under new coupled implicit relation in Hilbert spaces

36. Fenofibrate and risk of end‐stage renal disease: A nationwide cohort study.

37. Long‐term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52‐week extension of a Phase 3 randomized controlled trial.

Catalog

Books, media, physical & digital resources